Healthcare Costs

Novo Nordisk and Siemens Healthineers are rewriting the commercialization playbook by pairing blockbuster metabolic drugs with accessible blood diagnostics.

A $450 patent error opened Canada to generic semaglutide. Now, Novo Nordisk is using supply chain supremacy to beat back competitors and reclaim the market.

The American Association of Endodontists swept the PRSA Skyline Awards by treating viral TikTok misinformation as a critical market threat.

Koning Health’s recent TGA approval for its compression-free breast CT system signals a strategic shift in diagnostic imaging and patient compliance.

As the biosimilar wave hits rare diseases, Sandoz and mAbxience join forces to develop a complex bispecific alternative to Roche's $5.7B blockbuster Hemlibra.

Valley Oaks Health just secured a key grant to merge primary and mental care in rural Indiana. Here is why this integrated model is an economic necessity.

Heavy menstrual bleeding drives 600,000 surgeries a year. Hemab Therapeutics aims to replace invasive treatments with a once-a-month injection.

Matisse Pharmaceuticals secures €14 million to advance a radically different approach to sepsis, targeting cytotoxic histones to stop organ failure.

As payers use algorithms to deny claims, ARGO’s new AI tool helps behavioral health providers fight back, protecting margins and easing clinician burnout.

Psynergy Health's launch on the CMS directory signals a massive shift from passive software to accountable, AI-driven digital infrastructure for chronic care.

NanoTess co-founders Megan Leslie and Julian Mulia win Canada's Top 40 Under 40 for a catalytic technology that addresses a massive healthcare crisis.

A new transpacific partnership between Cellares and GenomeFrontier signals a critical shift in cell therapy, swapping viral vectors for automated precision.

How one Singaporean health system's quiet experiment in value-based care became a national playbook, saving millions and redefining patient outcomes.

With $14M from Khosla Ventures, AI startup Nara Health challenges the status quo with alternative plans, promising radical cost savings for employers.

How the 'Dirty Soda' pioneer turned a founder's personal crisis into a powerful CSR model that drives growth, brand loyalty, and life-saving impact.

With a new FDA nod for its rare disease drug Joenja, Pharming offers hope to young children, signaling a strategic shift in how we treat complex genetic disorders.

With FDA approval for its RefluxStop® device, Implantica challenges the GERD treatment status quo, promising better outcomes without debilitating side effects.

VensureHR’s new Direct Care offering isn't just another benefit. It’s a systemic shift, pushing a disruptive healthcare model into the corporate mainstream.

A new report reveals a silent crisis in healthcare: nearly half of organizations say document delays harm patients, creating an "action gap" that costs billions.

Nearly 37 million Americans face an invisible crisis of dizziness and imbalance, fueling a public health emergency. But new awareness and therapies offer a path to stability.